crizotinib &#160; ingelesa (Q5186964)

Crizotinib (ingelesa)

19 urria 2016

stereoisomer of ^ingelesa

3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine ^ingelesa

Erreferentzia bat

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

formula kimikoa

C₂₁H₂₂Cl₂FN₅O

Erreferentzia bat

Crizotinib (ingelesa)

19 azaroa 2016

SMILES

CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N

Erreferentzia bat

Crizotinib (ingelesa)

19 azaroa 2016

isomeric SMILES ^ingelesa

C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N

Erreferentzia bat

Crizotinib (ingelesa)

19 azaroa 2016

active ingredient in ^ingelesa

Xalkori ^ingelesa

Erreferentzia bat

RxNorm ^ingelesa

RxNorm ID ^ingelesa

1148499

14 otsaila 2018

World Health Organisation international non-proprietary name ^ingelesa

crizotinib (ingelesa)

Erreferentzia bat

ChEBI

crizotinib (ingelesa)

19 urria 2016

medical condition treated ^ingelesa

inflammatory myofibroblastic tumour ^ingelesa

Erreferentzia bat

2 urria 2018

non-small-cell lung carcinoma ^ingelesa

Erreferentzia bat

2 urria 2018

bronchus carcinoma ^ingelesa

Erreferentzia bat

2 urria 2018

neuroblastoma, susceptibility to ^ingelesa

Erreferentzia bat

2 urria 2018

significant drug interaction ^ingelesa

amiodarone ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ondansetron

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

arsenic trioxide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

disopyramide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sunitinib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

toremifene ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

dasatinib monohydrate ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

lapatinib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sorafenib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

anagrelide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

moxifloxazino

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

dronedarone ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

vandetanib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

droperidol ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pimozide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

haloperidol

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

klorpromazina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-citalopram ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

zuklopentixol

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pasireotide ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Hidroxizina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-sulpiride ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Metadona

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pazopanib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sotalol ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nilotinib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

voriconazole ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Eritromizina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Klaritromizina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Kinina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-metoprolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nadolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

atenolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nebivolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

acebutolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

betaxolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Digoxina

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Bisoprolol

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pindolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

carvedilol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

propranolol

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

labetalol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

clonidine ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

celiprolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

esmolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

levobunolol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

diltiazem ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sotalol ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pentamidine ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

mefloquine ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fingolimod ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

domperidone ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

bosutinib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ceritinib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Metadona

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

verapamil ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

amiodarone ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Alfentanilo

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Sufentanilo

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fingolimod ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pasireotide ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ivabradine ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

donepezil ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

seguruenik

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

galantamine ^ingelesa

side effect ^ingelesa

sinus bradycardia ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ivabradine ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ergotamina

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

arsenic trioxide ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sunitinib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

dasatinib monohydrate ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sorafenib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Taxol

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nilotinib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pentamidine ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

pazopanib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

bosutinib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

dabrafenib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ibrutinib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ceritinib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

idelalisib ^ingelesa

side effect ^ingelesa

bone marrow failure ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

amiodarone ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

dabrafenib ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

galantamine ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ketiapina

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-sulpiride ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Alfentanilo

side effect ^ingelesa

central respiratory depression ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

donepezil ^ingelesa

side effect ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

donepezil ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

seguruenik

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Sufentanilo

side effect ^ingelesa

central respiratory depression ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

itraconazole ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Erritonabir

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ketoconazole ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ivabradine ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

fosphenytoin ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tacrolimus ^ingelesa

side effect ^ingelesa

long QT syndrome ^ingelesa

Erreferentzia bat

fisikoki honekin elkarrekintza du

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

ALK receptor tyrosine kinase ^ingelesa

subjektuak duen rola

Entzimen inhibitzaile

Erreferentzia bat

IUPHAR/BPS Guide to PHARMACOLOGY ^ingelesa

17 abuztua 2016

MET proto-oncogene, receptor tyrosine kinase ^ingelesa

subjektuak duen rola

Entzimen inhibitzaile

Erreferentzia bat

IUPHAR/BPS Guide to PHARMACOLOGY ^ingelesa

17 abuztua 2016

pregnancy category ^ingelesa

Australian pregnancy category D ^ingelesa

Erreferentzia bat

iturria

Ingelesezko Wikipedia

US pregnancy category D ^ingelesa

Erreferentzia bat

iturria

Ingelesezko Wikipedia

LiverTox likelihood score ^ingelesa

LiverTox toxicity likelihood category C ^ingelesa

Erreferentzia bat

LiverTox ^ingelesa

https://www.ncbi.nlm.nih.gov/books/n/livertox/Crizotinib

8 apirila 2021

URL erreferentzia

azken eguneraketa

30 urria 2017

subjektuak duen rola

xenobiotic-transporting ATPase inhibitor ^ingelesa

Erreferentzia bat

NDF-RT ^ingelesa

NDF-RT ID ^ingelesa

N0000183253

5 martxoa 2018

protein kinase inhibitors ^ingelesa

Erreferentzia bat

Medical Subject Headings

MeSH identifikadorea

C551994

InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1

15 martxoa 2018

Commons-eko kategoria

Crizotinib

0 erreferentzia

Identifikatzaileak

InChI

Erreferentzia bat

Crizotinib (ingelesa)

19 azaroa 2016

2 erreferentzia

Crizotinib (ingelesa)

19 azaroa 2016

ChEBI release 2020-09-01 ^ingelesa

CAS zenbakia

877399-52-5

2 erreferentzia

crizotinib (ingelesa)

19 azaroa 2016

CAS Common Chemistry ^ingelesa

https://commonchemistry.cas.org/detail?cas_rn=877399-52-5

8 apirila 2021

URL erreferentzia

ChemSpider-ren identifikatzailea

9801307

Erreferentzia bat

ChemSpider-ren identifikatzailea

ChemSpider ^ingelesa

9801307

Crizotinib (ingelesa)

19 urria 2016

2 erreferentzia

Crizotinib (ingelesa)

19 azaroa 2016

Reaxys registry number ^ingelesa

12133926

Erreferentzia bat

ChEBI

crizotinib (ingelesa)

19 urria 2016

mapping relation type ^ingelesa

exact match ^ingelesa

2 erreferentzia

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL601719

CRIZOTINIB (ingelesa)

19 azaroa 2016

InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1

International Chemical Identifier ^ingelesa

InChI

ChEMBL-en identifikatzailea

CHEMBL601719

Erreferentzia bat

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL601719

CRIZOTINIB (ingelesa)

19 azaroa 2016

SureChEMBL ID ^ingelesa

SCHEMBL93829

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

UniChem compound ID ^ingelesa

53865

Erreferentzia bat

splash10-0udi-1693800000-fc52c38f3359a378554a

UniChem ^ingelesa

SPLASH ^ingelesa

0 erreferentzia

DSSTox substance ID ^ingelesa

DTXSID701009329

Erreferentzia bat

DSSTOX compound identifier ^ingelesa

DTXCID601436157

0 erreferentzia

LiverTox ID ^ingelesa

Crizotinib

0 erreferentzia

NSC number ^ingelesa

0 erreferentzia

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.166.440

27 abendua 2018

2-Pyridinamine,3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl] (ingelesa)

quotation ^ingelesa

CAS no.: 877399-52-5 (ingelesa)

ECHA Substance Infocard ID ^ingelesa

100.166.440

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.166.440

27 abendua 2018

2-Pyridinamine,3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl] (ingelesa)

quotation ^ingelesa

CAS no.: 877399-52-5 (ingelesa)

ATC kodea

L01XE16

Erreferentzia bat

DrugBank ^ingelesa

DrugBank ID ^ingelesa

08865

Crizotinib (ingelesa)

argitaratze-data

17 azaroa 2015

Erreferentzia bat

IUPHAR/BPS Guide to PHARMACOLOGY ^ingelesa

crizotinib (ingelesa)

19 azaroa 2016

Crizotinib

0 erreferentzia

MeSH kodea

D03.383.621.154

0 erreferentzia

D03.383.725.050.263

0 erreferentzia

RxNorm ID ^ingelesa

1148495

Erreferentzia bat

crizotinib (ingelesa)

19 azaroa 2016

DrugBank ID ^ingelesa

DB08865

Erreferentzia bat

2 erreferentzia

crizotinib (ingelesa)

19 azaroa 2016

MedlinePlus drug identifier ^ingelesa

a612018

0 erreferentzia

PatientsLikeMe treatment ID ^ingelesa

crizotinib

0 erreferentzia

NDF-RT ID ^ingelesa

N0000183253

Erreferentzia bat

crizotinib (ingelesa)

19 azaroa 2016

Probes And Drugs ID ^ingelesa

PD003326

0 erreferentzia

DrugCentral ID ^ingelesa

4187

Erreferentzia bat

KEGG-ren identifikatzailea

UniChem ^ingelesa

D09731

Erreferentzia bat

ChEBI

crizotinib (ingelesa)

Freebase-ren identifikatzailea

19 urria 2016

PDB ligand ID ^ingelesa

VGH

0 erreferentzia

electronic Essential Medicines List medicine ID ^ingelesa

585

0 erreferentzia

/m/0c418c1

Erreferentzia bat

Microsoft Academic identifikatzailea

Freebase Data Dumps ^ingelesa

argitaratze-data

28 urria 2013

2779422266

0 erreferentzia

OpenAlex identifikatzailea

Erreferentzia bat

26 urtarrila 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

4C9W

Erreferentzia bat

Protein Data Bank ^ingelesa

4C9W

4C9W (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

2WGJ

2WGJ (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

3ZBF

3ZBF (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

5AAA

5AAA (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

5AAC

5AAC (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

5AAB

5AAB (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

2XP2

2XP2 (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

4ANS

4ANS (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

4ANQ

4ANQ (ingelesa)

19 urria 2016

Erreferentzia bat

Protein Data Bank ^ingelesa

2YFX

2YFX (ingelesa)

19 urria 2016

Erreferentzia bat

crizotinib (ingelesa)